Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Clinical trial NCT04932967 · COMPLETED
Trial details
- NCT number
- NCT04932967
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-30
- Primary completion
- 2022-04-11
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.